Clinical trials
Corneal Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Recruiting | 12 |
| Unknown status | 10 |
| Terminated | 8 |
| Withdrawn | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daniela Nosch | 4 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 3 |
| Federal University of São Paulo | 3 |
| Massachusetts General Hospital | 3 |
| Suxia Li | 3 |
| CorNeat Vision Ltd. | 2 |
| Euclid Systems Corporation | 2 |
| Tufts Medical Center | 2 |
| Umeå University | 2 |
| Allergan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Corneal Diseases | 73 |
| Keratoconus | 8 |
| Dry Eye Syndromes | 7 |
| Eye Diseases | 7 |
| Cataract | 5 |
| Glaucoma | 5 |
| Corneal Injuries | 4 |
| Corneal Opacity | 4 |
| Keratitis | 4 |
| Diabetes Mellitus | 3 |
Trials
Showing 26 to 50 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.